These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6395017

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H, Luszpinski P.
    Z Hautkr; 1984 Sep 15; 59(18):1209-17. PubMed ID: 6388169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D, Reichenberger M.
    Mykosen; 1980 Dec 15; 23(12):657-68. PubMed ID: 7012610
    [No Abstract] [Full Text] [Related]

  • 7. New therapeutic approach in skin mycoses: a comparative trial once versus twice daily application of fenticonazole in comparison to miconazole.
    Vannini P, Difonzo EM, Cordaro CI, Sartani A, Panconesi E.
    Mycoses; 1988 May 15; 31(5):280-4. PubMed ID: 3047577
    [No Abstract] [Full Text] [Related]

  • 8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F, Gartmann H, Weidinger G.
    Z Hautkr; 1984 Sep 15; 59(18):1218-26. PubMed ID: 6388170
    [Abstract] [Full Text] [Related]

  • 9. [Double-blind comparative study of RO-13-8996 with miconazole in relation to its efficiency and local tolerance in patients with dermatomycosis].
    Arreaza de Arreaza F, Díaz de Torres E, Briceño Maaz T.
    Med Cutan Ibero Lat Am; 1984 Sep 15; 12(1):57-61. PubMed ID: 6376980
    [Abstract] [Full Text] [Related]

  • 10. [Contact allergy to the antifungal agent naftifin].
    Hoting E, Küchmeister B, Hausen BM.
    Derm Beruf Umwelt; 1987 Sep 15; 35(4):124-7. PubMed ID: 2959458
    [Abstract] [Full Text] [Related]

  • 11. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M, Péc J, Moravcík P.
    Cas Lek Cesk; 1993 Jun 28; 132(13):406-9. PubMed ID: 8370053
    [Abstract] [Full Text] [Related]

  • 12. [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
    Bojanovsky A, Haas P.
    Fortschr Med; 1985 Jul 04; 103(25):677-9. PubMed ID: 3897005
    [No Abstract] [Full Text] [Related]

  • 13. [The problem of external therapy used in skin mycosis].
    Tarasenko GN, Patronov IV, Kuz'mina IuV, Tarasenko IuG.
    Voen Med Zh; 2004 Aug 04; 325(8):38-9. PubMed ID: 15471414
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G, Giorgetti P, Santagostino L, Di Cintio R, Colombo MD.
    G Ital Dermatol Venereol; 1989 May 04; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis.
    el Darouti MA, Kalinka P.
    Int J Dermatol; 1990 Sep 04; 29(7):521-2. PubMed ID: 2228386
    [No Abstract] [Full Text] [Related]

  • 19. Topical tioconazole in dermatomycosis.
    Kuokkanen K.
    Mykosen; 1982 May 04; 25(5):274-80. PubMed ID: 7048088
    [No Abstract] [Full Text] [Related]

  • 20. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M, Hanafi S, al-Omari H, Mokhtar M, el-Shamy S, Mühlbacher J.
    Int J Dermatol; 1994 Aug 04; 33(8):570-2. PubMed ID: 7960355
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.